Clinical studies recruiting near Maitland

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 3 · Neurology Associates · Takeda · NCT06747351 A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Phase 2 · K2 Medical Research ORLANDO · Eli Lilly and Company · NCT05986292 Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
Phase 2 · Clinical Site · Intra-Cellular Therapies, Inc. · NCT06480383 Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis
Phase 3 · A48 · Cartesian Therapeutics · NCT06799247 A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson'
Phase 3 · K2 Medical Research-Maitland · Hoffmann-La Roche · NCT07174310 Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PE
Phase N/A · K2 Medical Research · GAP Innovations, PBC · NCT06584357 A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
Phase 1 · K2 Medical Research · Eli Lilly and Company · NCT06657768 A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Phase 3 · 89bio Clinical Study Site · 89bio, Inc. · NCT06419374 Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associate
Phase 3 · K2 Medical Research - Maitland · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05980949 Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Maj
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT06966401 A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Phase 2 · K2 Medical Research ORLANDO · Eli Lilly and Company · NCT07285018 A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Phase 3 · K2 Medical Research (Maitland) · Definium Therapeutics US, Inc. · NCT07592689 A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson'
Phase 2/Phase 3 · Site-051 · Biohaven Therapeutics Ltd. · NCT06976268 A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
Phase 1 · K2 Medical Research, LLC · Eli Lilly and Company · NCT06297590 A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Gener
Phase 3 · Neurology Associates PA · Novartis Pharmaceuticals · NCT06744920 A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT
Phase 3 · K2 Medical Research - Maitland · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05511363 Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT07227818 A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
Phase 2 · Accel Research Sites Network · Navigator Medicines, Inc. · NCT07384975 SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
Phase 1 · K2 Medical Research LLC · Serina Therapeutics · NCT07422675 Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosis
Phase 3 · The George Institute · NCT05752279 A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Mult
Phase N/A · TG Therapeutics Investigational Trial Site · TG Therapeutics, Inc. · NCT06433752 NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT07114874 A Study to Assess the Efficacy and Safety of Solriamfetol in Children With ADHD
Phase 3 · Clinical Research Site · Axsome Therapeutics, Inc. · NCT07717879 "A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
Phase 3 · K2 Medical Research-Maitland · Cybin IRL Limited · NCT06564818 A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
Phase 2 · K2 Medical Research ORLANDO · Eli Lilly and Company · NCT07223840 A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT
Phase 3 · Local Institution - 1039 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT06126224 A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
Phase 2 · K2 Medical Research · Intra-Cellular Therapies, Inc. · NCT06540833 A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
Phase 2 · Accel Research Sites - Maitland Clinical Research Unit · Eli Lilly and Company · NCT07286175 A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Al
Phase 3 · Local Institution - 1622 · Bristol-Myers Squibb · NCT07011732 Open-label Extension Study in Participants With Early Alzheimer's Disease
Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT07105709

Look up another city

Look up another condition